LONDON, Aug. 15, 2017 /PRNewswire/ -- North West London
Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust,
and Abbott (NYSE: ABT) announced today that they signed a
$252 million managed equipment
services contract for the supply of all analytical equipment and
consumables, including Abbott's Alinity™ ci and Alinity h series
diagnostics instruments as well as their professional services and
informatics solutions known as AlinIQ.
The contract was the subject of a detailed and competitive
procurement process conducted by NWLP. Imperial College Healthcare
NHS Trust, Chelsea and Westminster NHS Foundation Trust and the
Hillingdon Hospitals NHS Foundation Trust consolidated their
pathology services into NWLP earlier this year to better manage
demand, standardize operations, improve value for money and make
use of new technologies.
Stephen Snewin, managing director of NWLP, said: "NWLP aims to
provide an innovative and sustainable pathology service which
delivers outstanding quality for our patients and clinicians. After
a highly competitive process involving multiple diagnostic
equipment manufacturers, NWLP is extremely excited to be working
with Abbott, which supports our vision of increased efficiency and
transformation across six major sites in North West London using the latest
technology."
The partnership is expected to manage 26 million tests per year
and currently holds 6 percent of the total pathology market in the
UK.
"Abbott is delighted to provide NWLP with personalized Alinity
and AlinIQ solutions to help them navigate the challenges of an
evolving healthcare system," said Mike
Clayton, managing director, Northern Europe, for Abbott's diagnostics
business. "Through our partnership, we will equip NWLP to help
maximize productivity, drive faster delivery of test results and
provide the critical information needed for clinical decisions –
with the goal of helping the Trust improve patient outcomes."
The hospitals included within this partnership are: Imperial
College Healthcare NHS Trust, which comprises St Mary's Hospital,
Charing Cross Hospital, Hammersmith Hospital, Queen Charlotte and
Chelsea Hospital and the Western Eye Hospital; Chelsea &
Westminster Hospital Foundation Trust, which comprises Chelsea
& Westminster Hospital and West Middlesex University Hospital;
and Hillingdon Hospitals NHS Foundation Trust, which comprises
Hillingdon Hospital and Mount Vernon Hospital.
About Imperial College Healthcare NHS Trust:
Imperial College Healthcare NHS Trust is one of the largest
hospital Trusts in England,
providing acute and specialist healthcare for a population of
nearly two million people. The Trust has five hospitals –
Charing Cross, Hammersmith, Queen
Charlotte's & Chelsea, St Mary's and The Western Eye – as well
as community services.
About Alinity:
Abbott's Alinity family of harmonized solutions is unprecedented in
the diagnostics industry, working together to address the
challenges of using multiple diagnostics platforms and simplify
diagnostic testing. Alinity systems are designed to be more
efficient – running more tests in less space, generating test
results faster and minimizing human errors – while continuing to
provide quality results.
The Alinity portfolio includes Alinity c (clinical chemistry),
Alinity i (immunoassay), Alinity s (blood and plasma screening),
i-STAT Alinity (point of care), Alinity h (hematology) and Alinity
m (molecular) diagnostics, along with Abbott's AlinIQ—a
first-of-its-kind, holistic suite of professional services that
combines expertise with process analysis and informatics. Alinity
is helping labs and hospital systems solve some of their most
pressing challenges to deliver better patient care with fewer
resources. More information is available at abbott.com/alinity.
About Abbott:
At Abbott, we're committed to helping you live your best possible
life through the power of health. For more than 125 years, we've
brought new products and technologies to the world -- in nutrition,
diagnostics, medical devices and branded generic pharmaceuticals --
that create more possibilities for more people at all stages of
life. Today, 94,000 of us are working to help people live not just
longer, but better, in the more than 150 countries we serve.
View original content with
multimedia:http://www.prnewswire.com/news-releases/north-west-london-pathology-and-abbott-partner-for-diagnostics-products-and-services-including-alinity-in-three-nhs-trusts-300503997.html
SOURCE Abbott